Deepverge has published initial data from its ongoing Phase III clinical studies for the detection of SARS-CoV-2 from samples of breath condensate and identification of confirmed COVID-19 positive patients.
Deepverge PLC (DVRG.L) Microtox® BT Eval’n of SARS-CoV-2 from breath test
Microtox ® BT Evaluation of SARS-CoV-2 from breath test with Clinical Samples
Deepverge PLC (DVRG.L) Award Nomination in China
Nomination for Outstanding New Environmental Monitoring Product of the Year in China 2020
TPI provides its latest research note on DeepVerge plc (DVRG.L).
Deepverge has today announced its appointment of a former IBM Legal Counsel as inhouse lawyer and Company Secretary. Fiona Joyce’s engagement is seen as an important signal from the Board,
Gerard J Brandon, CEO of Deepverge PLC (DVRG.L) Interview
Deepverge (formerly Integumen) is a vertically integrated business, collaborating technology platforms with partners in artificial intelligence, clinical research, water technologies, medical device and life science.